Latest Asx Continuous Disclosure News

DY6 Metals has clarified its compliance with ASX continuous disclosure rules following a material capital raising and CEO appointment, confirming timely and confidential handling of sensitive information.

Perpetual Resources has addressed ASX concerns over recent trading activity, attributing the surge to its latest drilling progress and positive market sentiment in Brazilian minerals.

Raptis Group Limited has confirmed that director James Raptis will resign effective 30 September 2025, affirming the company’s compliance with ASX continuous disclosure rules.

Latrobe Magnesium Limited has addressed ASX concerns over recent share price and volume spikes, attributing the market activity to recognition of its asset value and the imminent start of its demonstration plant.

Arika Resources has responded to an ASX price query, confirming no undisclosed information behind recent share price movements and highlighting its active drilling program and recent $5 million capital raise.

Resolution Minerals has addressed ASX concerns over recent share price and volume spikes, attributing the activity to ongoing developments in its US Horse Heaven project acquisition.

Raptis Group Limited has confirmed the resignation of director James Raptis effective September 30, 2025, amid a sharp rise in its share price and trading volume. The company denies any other undisclosed information behind the recent market activity.

Australian Rare Earths (ASX, AR3) has responded to an ASX price query, denying any undisclosed price-sensitive information and attributing recent trading activity to sector interest and recent company announcements.

Bowen Coking Coal Limited (BCB) has responded to ASX inquiries about its liquidity challenges, working capital needs from transitioning to an owner-operator model, and deteriorating operating margins, affirming compliance and financial viability despite market pressures.

Alterity Therapeutics has responded to an ASX inquiry about its recent share price and volume spike, confirming no undisclosed information but highlighting imminent clinical data releases and investor roadshows as possible drivers.

AML3D Limited has confirmed it complied with ASX continuous disclosure rules regarding its recent Letter of Intent with the US Navy, clarifying the timing of its awareness and announcement.

Biome Australia Limited has confirmed its record FY25 sales revenue of approximately $18.4 million, marking a 41% increase year-on-year, while affirming full compliance with ASX continuous disclosure rules.